TRCT
PMI

Tower Research Capital (TRC)’s Picard Medical PMI Stock Holding History

Tower Research Capital (TRC)’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95K Buy
238
+180
+310% +$3.83K ﹤0.01% 4743
2026
Q1 		$3.02K Buy
58
+56
+2,800% +$4.06K ﹤0.01% 4377
2025
Q4 		$201 Buy
+2
New +$471 ﹤0.01% 4994

Other funds holding PMI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Tower Research Capital (TRC)'s PMI Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Picard Medical (PMI) stake by 310% in Q2 2026, buying an estimated $3.83K and bringing the position to 238 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4743.

Tower Research Capital (TRC) first reported a position in PMI in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.02K in Q1 2026. 41 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • Tower Research Capital (TRC) held 238 shares of Picard Medical worth $1.95K as of Q2 2026.
  • Tower Research Capital (TRC) bought 180 Picard Medical shares in Q2 2026, an estimated $3.83K.
  • Picard Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4743 holding.
  • Tower Research Capital (TRC) first reported a position in Picard Medical in Q4 2025 and has held it in 3 quarters since.
  • Tower Research Capital (TRC)'s Picard Medical position peaked at $3.02K in Q1 2026.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.